- Home
- AMRN vs MASS Comparison
AMRN vs MASS Comparison
Compare AMRN & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- MASS
- Stock Information
- Founded
- AMRN 1989
- MASS 2012
- Country
- AMRN Ireland
- MASS United States
- Employees
- AMRN N/A
- MASS N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- MASS Medical/Dental Instruments
- Sector
- AMRN Health Care
- MASS Health Care
- Exchange
- AMRN Nasdaq
- MASS Nasdaq
- Market Cap
- AMRN 302.0M
- MASS 324.4M
- IPO Year
- AMRN 1993
- MASS 2020
- Fundamental
- Price
- AMRN $19.18
- MASS $9.04
- Analyst Decision
- AMRN Strong Sell
- MASS Strong Buy
- Analyst Count
- AMRN 1
- MASS 3
- Target Price
- AMRN $12.00
- MASS $8.00
- AVG Volume (30 Days)
- AMRN 144.3K
- MASS 323.0K
- Earning Date
- AMRN 10-29-2025
- MASS 11-10-2025
- Dividend Yield
- AMRN N/A
- MASS N/A
- EPS Growth
- AMRN N/A
- MASS N/A
- EPS
- AMRN N/A
- MASS N/A
- Revenue
- AMRN $219,361,000.00
- MASS $65,560,000.00
- Revenue This Year
- AMRN N/A
- MASS N/A
- Revenue Next Year
- AMRN N/A
- MASS $22.29
- P/E Ratio
- AMRN N/A
- MASS N/A
- Revenue Growth
- AMRN N/A
- MASS 37.93
- 52 Week Low
- AMRN $7.08
- MASS $1.81
- 52 Week High
- AMRN $20.90
- MASS $9.34
- Technical
- Relative Strength Index (RSI)
- AMRN 58.42
- MASS 54.75
- Support Level
- AMRN $19.02
- MASS $8.17
- Resistance Level
- AMRN $20.90
- MASS $8.76
- Average True Range (ATR)
- AMRN 0.93
- MASS 0.49
- MACD
- AMRN -0.15
- MASS -0.10
- Stochastic Oscillator
- AMRN 40.81
- MASS 49.40
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.